Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
Researchers have discovered a chemical that makes cells in the retinas of blind mice sensitive to light, temporarily restoring some vision.
They are working on an improved compound that they hope could one day be used to restore sight in human patients suffering from retinitis pigmentosa, the most common form of inherited blindness, and macular degeneration, the most common cause of acquired blindness in the developed world. 
No comment yet.
Sign up to comment
Scoop.it!
Medical researchers expect that with whole genome sequencing, treatment will be tailored to an individual tumor’s mutations, with drugs, eventually, that hit several key aberrant genes at once.
What is important, the researchers say, is the genes that drive a cancer, not the tissue or organ — liver or brain, bone marrow, blood or colon — where the cancer originates.
|
Scoop.it!
A Harvard researcher studying the evolution of drug resistance in cancer says that, in a few decades, “many, many cancers could be manageable.”
“Many people are dying needlessly of cancer, and this research may offer a new strategy in that battle,” said Martin Nowak, a professor of mathematics and of biology and director of the Program for Evolutionary Dynamics.
“One hundred years ago, many people died of bacterial infections. Now, we have treatment for such infections — those people don’t have to die. I believe we are approaching a similar point with cancer.”
Scoop.it!
One of the great frustrations for researchers in the war on cancer is that the body’s own defense system does not do a better job fighting the disease. Tumors, it turns out, have a molecular shield that repels attacks from the immune system.
Now, a new study says, an experimental drug is showing promise in disabling that shield...
|
